D

진시스템

363250KOSDAQ의료용 기기 제조업

38.0 / 100

Reference Date: 2026-04-13

Financial Score4.5 / 40
News Sentiment7.5 / 25
Momentum14.0 / 20
Disclosure12.0 / 15
AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Surged 37.9% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Jin System specializes in the development and manufacturing of molecular diagnostic solutions, offering compact PCR systems and biochips that achieved 83.52% export sales in 2024. The company is expanding its market through innovative platforms integrating IT technologies and cost-effective on-site diagnostic products.

Number of Employees

52people

Average Salary

58.0M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 26.524.0Point
PBR
7.03Industry Average 1.700.0Point

4.1x industry avg (risky)

ROE
-99.02Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
53.05Industry Average 10.950.0Point

4.8x industry avg (risky)

Trend 2023~20250.5 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼16.9% (2-year basis)

Operating Profit Growth Rate
0.5 / 3

Avg ▼1.2% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -53.3% (declining, 3yr)

Detailed News Sentiment

1 totalPositive 0Neutral 1Negative 0Average Sentiment Score 30

Detailed Momentum

52-week position5.0Point

52w mid range (46%)

Current 6,990Won52-week high 11,00052-week low 3,520
1-month return6.0Point

1m +37.87% (strong rise)

Volume trend3.0Point

Volume flat

Detailed Disclosure

15 totalPositive 1Neutral 14Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-04-07
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-07
  • Neutral주식등의대량보유상황보고서(일반)2026-04-07
  • Neutral기타시장안내 (최대주주의 의무보유 관련)(최대주주의 의무보유 이행 관련)2026-04-02
  • Neutral[기재정정]정기주주총회결과2026-04-01